Correlation Between XSpray Pharma and Sdiptech

Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and Sdiptech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and Sdiptech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between XSpray Pharma AB and Sdiptech AB, you can compare the effects of market volatilities on XSpray Pharma and Sdiptech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of Sdiptech. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and Sdiptech.

Diversification Opportunities for XSpray Pharma and Sdiptech

0.89

Correlation Coefficient

XSpray Pharma  Sdiptech

Very poor diversification

The 3 months correlation between XSpray and Sdiptech is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and Sdiptech AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sdiptech AB and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with Sdiptech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sdiptech AB has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and Sdiptech go up and down completely randomly.

Pair Corralation between XSpray Pharma and Sdiptech

Assuming the 90 days trading horizon XSpray Pharma AB is expected to generate 1.88 times more return on investment than Sdiptech. However, XSpray Pharma is 1.88 times more volatile than Sdiptech AB. It trades about 0.16 of its potential returns per unit of risk. Sdiptech AB is currently generating about 0.14 per unit of risk. If you would invest  3,080  in XSpray Pharma AB on May 21, 2025 and sell it today you would earn a total of  1,280  from holding XSpray Pharma AB or generate 41.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

XSpray Pharma AB  vs.  Sdiptech AB

XSpray Pharma AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in XSpray Pharma AB are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, XSpray Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Sdiptech AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sdiptech AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Sdiptech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with XSpray Pharma and Sdiptech

The main advantage of trading using opposite XSpray Pharma and Sdiptech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, Sdiptech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sdiptech will offset losses from the drop in Sdiptech's long position.

The idea behind XSpray Pharma AB and Sdiptech AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.